loadpatents
Patent applications and USPTO patent grants for Kim; Namdoo.The latest application filed is for "pyrrolopyrimidine inhibitors of wild-type and mutant forms of lrrk2".
Patent | Date |
---|---|
Pyrrolopyrimidine Inhibitors Of Wild-type And Mutant Forms Of Lrrk2 App 20220204515 - Gray; Nathanael S. ;   et al. | 2022-06-30 |
Pyrrolopyridine Derivative And Use Thereof In Prevention And Treatment Of Protein Kinase-related Disease App 20220064161 - JUNG; Myungho ;   et al. | 2022-03-03 |
Azaindole Inhibitors Of Wild-type And Mutant Forms Of Lrrk2 App 20210347772 - Gray; Nathanael S. ;   et al. | 2021-11-11 |
N-(3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methylphenyl)-5-phenyl-4,5-di- Hydro-1h-pyrazole-1-carboxamide Derivative, And Pharmaceutical Composition Containing Same As Active Ingredient For Treating Kinase-related Diseases App 20210284647 - LI; Hua ;   et al. | 2021-09-16 |
Membrane Module And Membrane Module Assembly, And Immersion-type Layer-sepa-rating Apparatus Including Same App 20120160750 - Choi; Woong ;   et al. | 2012-06-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.